Syrris

Syrris

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2.5M

Overview

Syrris is a privately-held, revenue-generating technology company that designs and manufactures sophisticated automated systems for flow and batch chemistry. Its product portfolio, including the Asia flow chemistry systems, Atlas HD, Orb, and Orb Pilot reactors, is used globally for process development, discovery chemistry, and scale-up, with a strong presence in top pharmaceutical companies. As part of the AGI Group, Syrris leverages a global distribution and manufacturing network to provide integrated solutions from lab to pilot scale, supported by a high customer satisfaction metric (NPS of 60) and over 600 peer-reviewed publications validating its technology.

Drug DeliverySmall Molecules

Technology Platform

Modular automated systems for flow chemistry, batch chemistry reactors, chemical scale-up, and reaction calorimetry, enabling precise control and data-rich experimentation for chemical synthesis and process development.

Funding History

1
Total raised:$2.5M
Series A$2.5M

Opportunities

Strong demand is driven by pharmaceutical industry trends towards continuous manufacturing and faster process development, as well as a broader industrial shift towards green chemistry and sustainable processes.
Expansion into adjacent markets like specialty chemicals, agrochemicals, and fragrance, coupled with the ability to offer integrated lab-to-pilot solutions through the AGI Group, presents significant growth potential.

Risk Factors

Faces intense competition in the lab equipment market and is susceptible to cyclical fluctuations in R&D spending from its core pharmaceutical and academic customers.
The pace of adoption for advanced flow chemistry and automation technologies can be slow, requiring continuous market education and demonstration of return on investment.

Competitive Landscape

Competes with other specialized providers of flow chemistry systems (e.g., Chemtrix, Vapourtec) and broader laboratory reactor/calorimetry companies (e.g., Büchi, Mettler Toledo). Its key differentiator is its integrated portfolio covering flow, batch, and scale-up, combined with the manufacturing and global reach of its parent company, AGI Group.